步长制药：10月29日召开董事会会议

Group 1 - Company announced the convening of the 34th meeting of the fifth board of directors on October 29, 2025, via communication method [1] - The meeting reviewed the proposal to cancel the supervisory board and adjust the number of directors [1] - For the year 2024, the company's revenue composition is 99.71% from the pharmaceutical industry and 0.29% from other businesses [1] Group 2 - The current market capitalization of the company is 19.1 billion yuan [1]